摘要
目的:观察Ahmed青光眼阀植入及其联合手术治疗难治性青光眼的临床疗效。方法:回顾在我院行Ahmed青光眼阀植入及其联合手术的难治性青光眼病例45例,对他们手术前后的视力,眼压,术后并发症及其防治措施等进行总结分析。结果:难治性青光眼45例(45眼)实行了Ahmed青光眼阀植入术或联合晶状体摘除、玻璃体切割、人工晶状体植入术等;术后平均观察(3～18)9.7mo;患者术前的平均眼压36.8±12.3mmHg,术后平均眼压18.0±4.5mmHg;手术成功率87%;术后最佳矫正视力提高16眼(35%),视力无变化21眼(47%),视力降低8眼(18%);术后早期最常见的并发症是一过性浅前房及低眼压,发生率为20%,晚期最常见的并发症是滤过泡包裹,发生率是13%。结论:Ahmed青光眼阀植入及其联合术治疗难治性青光眼是相对安全和有效的。
AIM： To evaluate the effect and complications of the treatment of refractory glaucoma with Ahmed Glaucoma Valve implant and its combination surgery.
METHODS： This retrospective study reviewed the final intrcocular pressure, visual outcome, and incidence of complications in all patients with Ahmed glaucoma valve implant and its combination surgery performed in our hospital.
RESULTS： A total of 45 eyes from 45 patients were treated with the Ahmed glaucoma valve implant and its combination surgery. At a mean follow up of 9.7 months （range3- 18months）, the mean intraocular pressure was reduced from 36.8±12.3mmHg before the implant surgery to 18.0±4.5mmHg at the last follow up after surgery. The success rate was 87%. The best postoperative corrected visual acuity improved 16 eyes（35%）.Transient postoperative hypotony and shallow anterior chamber occurred in 20% of cases. The common postoperative complication in later was the formation of encapsulated bleb（13% ）.
CONCLUSION： Ahmed glaucoma valve implant and its combination surgery are effective and relatively safe for treating refractory glaucoma.
出处
《国际眼科杂志》
CAS
2007年第2期563-565,共3页
International Eye Science
关键词
难治性青光眼
植入物
手术治疗
疗效
refractory glaucoma
valve implant
combination surgery
